首页/数据集/Expression data from EZH2 inhibitor treated Non-Hodgkins Lymphoma cell lines

Expression data from EZH2 inhibitor treated Non-Hodgkins Lymphoma cell lines

ChEBI2014-02-19 更新2026-07-21 收录

肿瘤药物基因组学

表观遗传药物作用机制

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-49284 数据链接链接失效反馈

官方服务：

资源简介：

Expression data from EZH2 inhibitor treated Non-Hodgkins Lymphoma cell lines

应用场景：

创建时间：

2014-02-19

肿瘤药物基因组学

个性化用药

Pharmacogenetics is the relationship between an individual’s genetic variations and their response to pharmacological treatment. We conducted an overview of reviews on the use of post-treatment pharma

DataCite Commons2024-05-17 更新60

Supplementary Table 7 from Pharmacogenomic Profiling and Pathway Analyses Identify MAPK-Dependent Migration as an Acute Response to SN38 in p53 Null and p53-Mutant Colorectal Cancer Cells

肿瘤药物基因组学

结肠癌药物机制

PDF file - 11K, Results from KEGG pathway analysis for p53 wild-type and p53 null basal comparison. The table shows the number of genes in each pathway and the p value associated with that pathway cal

NIAID Data Ecosystem40

Table S5 from Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures

肿瘤药物基因组学

药物敏感性预测

Supplementary Table 5 LOBICO data

Figshare2023-09-05 更新30

Table S2 from Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures

肿瘤药物基因组学

肿瘤细胞模型

Supplementary Table 2 pancancer clinical info

NIAID Data Ecosystem50

Table S7 from Pan-Cancer Pharmacogenomic Analysis of Patient-Derived Tumor Cells Using Clinically Relevant Drug Exposures